Frazier’s acquisition will accelerate Apollo’s strategy for bringing transformative change to the healthcare and life science industries
SEATTLE, WA and WATERTOWN, MA—June 7, 2022—Frazier Healthcare Partners (Frazier), a Seattle-based, healthcare-focused private equity firm, announces the completion of its acquisition of Apollo Intelligence (Apollo), a leading provider of real-time data and insights to the healthcare and life science industries. Frazier’s investment, experience, and deep industry knowledge will accelerate Apollo’s ambitious vision for the healthcare and life science spaces.
Apollo was founded in 2019 by a group of experienced industry leaders and investors. The Apollo platform launched with its acquisition of InCrowd, a pioneer of real-time, automated insights for the life science industry, as the founding company. In 2020, Apollo acquired Survey Healthcare Global, a global market leader of first-party healthcare data collection and custom survey solutions, to complement InCrowd and strengthen its global reach. Through these innovative solutions, Apollo is executing its mission to accelerate health innovation to improve life—creating new, high-quality paths to research and insights.
Apollo’s unique integration of healthcare stakeholder access, powerful tech-enabled analytic tools, and domain expertise enables global healthcare organizations to efficiently develop, refine, and deliver life-changing innovations.
“We are thrilled with the business we have built and even more excited about Apollo’s next chapter as part of the Frazier family,” said Daniel S. Fitzgerald, CEO of Apollo Intelligence. “As we considered investment partners to help pursue our bigger vision, we recognized our alignment with the Frazier team almost immediately. Like Apollo, Frazier is committed to supporting technological advancements to improve healthcare. Frazier’s reputation and track record as a preeminent investor to innovative firms in healthcare, combined with a wealth of relevant experience, made the Frazier team a compelling choice.”
Apollo will continue to focus on elevating industry standards for research and data-driven insights. The new relationship with Frazier—extending Apollo’s value to healthcare and life science clients—will fuel innovation and scale.
“We are very excited about our investment in Apollo. As a leader in providing rapid insights that accelerate time to market for life science companies, Apollo is at the forefront of technological innovation within healthcare market research,” noted Christina Reszka, partner at Frazier. “We are especially pleased to have the opportunity to partner with Dan and the rest of the Apollo leadership team, an exceptional group of leaders who share our core values and focus on sustainable growth.”
Frazier Executive in Residence, Vivek Sharma, will join Apollo as executive chairman on the board of directors. Mr. Sharma has extensive experience leading tech-enabled healthcare services organizations supporting the life science end market, including most recently as CEO of Decision Resources Group (DRG) before its sale to Clarivate. Frazier Center of Excellence Partner, Ken McLaren, will similarly play a meaningful role in developing and executing Apollo’s growth strategy, leveraging his prior experiences as SVP of data analytics and insights at Clarivate and chief strategy officer at DRG.
Assisting in this agreement was Kirkland & Ellis, acting as legal advisor to Frazier. Apollo was advised by Canaccord Genuity LLC (lead financial advisor), Houlihan Lokey Capital, Inc. (co-financial advisor), and the law firm of Goodwin Procter, LLP.
About Apollo Intelligence, LLC
Apollo Intelligence’s mission is to accelerate health innovation to improve life. In 2019, Apollo launched with the acquisition of InCrowd, the pioneer of real-time, automated insights for the life science industry. To complement InCrowd and strengthen its global reach, in 2020, Apollo acquired Survey Healthcare Global, a global market leader of first-party healthcare data collection and custom survey solutions. Apollo provides access to 2 million healthcare stakeholders worldwide—including physicians, patients, caregivers, and allied healthcare professionals. Apollo’s 220+ employees support top global pharmaceutical brands, market research agencies, and consultancies across 13 different countries in the Americas, Europe, and Asia. For more information about Apollo, please visit our website at www.apollointelligence.net.
About Frazier Healthcare Partners
Founded in 1991, Frazier Healthcare Partners is a leading middle-market private equity firm focused exclusively on the healthcare sector. With over $7.1 billion in total capital raised, Frazier has invested in more than 200 companies with transaction types ranging from buyouts of profitable healthcare services companies to venture capital and company creation. Frazier has a philosophy of partnering with strong management teams while leveraging its internal operating resources and network to build exceptional companies. Frazier has offices in Seattle, WA, and Menlo Park, CA, and invests broadly across the U.S., Canada, and Europe. For more information about Frazier Healthcare Partners, visit www.frazierhealthcare.com.
Frazier Healthcare Partners
Carol Eckert, VP of Investor Relations
Mary Kae Marinac, Apollo PR Representative